Ofatumumab

Tax included
Ofatumumab is a fully human anti-CD20 monoclonal antibody that induces antibody-dependent cell-mediated cytotoxicity and complement-dependent cytotoxicity in CD20-expressing B lymphocytes.
MedChemExpress 
HY-P9961

Data sheet

Size
Multiple sizes
Reactivity
CD20
Application
Cancer-programmed cell death
CAS
679818-59-8